Activity
-
Excited to finally share the lab's first contribution to the burgeoning field of #MachineLearning-based #EarlyDetection of #dementia/#Alzheimer's…
Excited to finally share the lab's first contribution to the burgeoning field of #MachineLearning-based #EarlyDetection of #dementia/#Alzheimer's…
Liked by Thomas Fuchs
-
🌟 Join us for the symposium session at the First Annual Congress of the Asian Society of Digital Pathology! 📚 Symposium 5: Advancements in…
🌟 Join us for the symposium session at the First Annual Congress of the Asian Society of Digital Pathology! 📚 Symposium 5: Advancements in…
Liked by Thomas Fuchs
Experience
Honors & Awards
-
Barbara T. Murphy Endowed Professorship for Artificial Intelligence and Human Health
Icahn School of Medicine at Mount Sinai
-
The 100 Leading Pioneers Of AI Drug Development
Forbes
-
Heritage Research Investigators in Translational Medicine Award
CRAIN's
Awarded to an individual based on the most significant quantitative results achieved by accelerating the transition of novel and innovative diagnostic tools and treatments to patients.
More activity by Thomas
-
Paige and Indica Labs have announced a non-exclusive partnership to expand AI for anatomic pathology labs by integrating Paige's Diagnostic AI…
Paige and Indica Labs have announced a non-exclusive partnership to expand AI for anatomic pathology labs by integrating Paige's Diagnostic AI…
Liked by Thomas Fuchs
-
We recently announced that Paige would transition our diagnostic AI applications from being exclusive to the Paige Platform to a standalone solution…
We recently announced that Paige would transition our diagnostic AI applications from being exclusive to the Paige Platform to a standalone solution…
Liked by Thomas Fuchs
-
📰 Paige, working with Microsoft, has introduced two new AI models called Virchow2 and Virchow2G that are set to make a big difference in how we…
📰 Paige, working with Microsoft, has introduced two new AI models called Virchow2 and Virchow2G that are set to make a big difference in how we…
Liked by Thomas Fuchs
-
With the increasing number of foundation models being developed -- and often made publicly available -- it is now important to be able to compare…
With the increasing number of foundation models being developed -- and often made publicly available -- it is now important to be able to compare…
Liked by Thomas Fuchs
-
Proud Dad moment!! 🎓 Sharing a bittersweet moment as we drop off our oldest at The University of Texas at Austin this past weekend, joining the…
Proud Dad moment!! 🎓 Sharing a bittersweet moment as we drop off our oldest at The University of Texas at Austin this past weekend, joining the…
Liked by Thomas Fuchs
-
I am pleased to announce that our research paper, "Sexually dimorphic computational histopathological signatures prognostic of overall survival in…
I am pleased to announce that our research paper, "Sexually dimorphic computational histopathological signatures prognostic of overall survival in…
Liked by Thomas Fuchs
-
📣 Program update! 📣 We're thrilled to announce the official program schedule for our upcoming workshop at #MICCAI2024! 🎉 We have an incredible…
📣 Program update! 📣 We're thrilled to announce the official program schedule for our upcoming workshop at #MICCAI2024! 🎉 We have an incredible…
Liked by Thomas Fuchs
-
Our newly published research demonstrates how OmniScreen can predict over 1,200 molecular biomarkers from routine H&E-stained pathology slides across…
Our newly published research demonstrates how OmniScreen can predict over 1,200 molecular biomarkers from routine H&E-stained pathology slides across…
Liked by Thomas Fuchs
-
Shoutout to high school student Tanisee Nagaldinne, who interned this summer in Ipek Ensari's lab. She conducted research on chronic pelvic pain…
Shoutout to high school student Tanisee Nagaldinne, who interned this summer in Ipek Ensari's lab. She conducted research on chronic pelvic pain…
Liked by Thomas Fuchs
-
Paige has launched OmniScreen, an advanced AI-driven biomarker module capable of analyzing over 505 genes and detecting 1,228 molecular biomarkers…
Paige has launched OmniScreen, an advanced AI-driven biomarker module capable of analyzing over 505 genes and detecting 1,228 molecular biomarkers…
Liked by Thomas Fuchs
-
Hopefully a helpful guide for clinicians interested in pursuing digital health research- a growing field with the potential to improve our understand…
Hopefully a helpful guide for clinicians interested in pursuing digital health research- a growing field with the potential to improve our understand…
Liked by Thomas Fuchs
-
Paige's new AI module, OmniScreen, is capable of predicting a wide range of clinically relevant molecular biomarkers across multiple cancer types. By…
Paige's new AI module, OmniScreen, is capable of predicting a wide range of clinically relevant molecular biomarkers across multiple cancer types. By…
Liked by Thomas Fuchs
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Thomas Fuchs in United States
80 others named Thomas Fuchs in United States are on LinkedIn
See others named Thomas Fuchs